{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:35:38Z","timestamp":1756636538885},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,31]]},"DOI":"10.7759\/cureus.16779","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T15:16:58Z","timestamp":1627744618000},"source":"Crossref","is-referenced-by-count":3,"title":["Levetiracetam for the Prophylaxis of Migraine in Adults"],"prefix":"10.7759","author":[{"given":"Gauhar M","family":"Azeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filzah","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimrah","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danish","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Usama","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016. a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017, 390:1211-59. 10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38.1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/head.13665","article-title":"Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review","volume":"60","author":"Burch R","year":"2020","unstructured":"Burch R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache. 2020, 60:200-16. 10.1111\/head.13665","journal-title":"Headache"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70062-0","article-title":"Epidemiology and comorbidity of headache","volume":"7","author":"Jensen R","year":"2008","unstructured":"Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008, 7:354-61. 10.1016\/S1474-4422(08)70062-0","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/head.12038","article-title":"Contributions of epidemiology to our understanding of migraine","volume":"53","author":"Merikangas KR","year":"2013","unstructured":"Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache. 2013, 53:230-46. 10.1111\/head.12038","journal-title":"Headache"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.10.003","article-title":"Migraine and tension-type headache: diagnosis and treatment","volume":"103","author":"Burch R","year":"2019","unstructured":"Burch R. Migraine and tension-type headache: diagnosis and treatment. Med Clin North Am. 2019, 103:215-33. 10.1016\/j.mcna.2018.10.003","journal-title":"Med Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0734-1","article-title":"Primary headache disorders in the adult general population of Pakistan - a cross sectional nationwide prevalence survey","volume":"18","author":"Herekar AA","year":"2017","unstructured":"Herekar AA, Ahmad A, Uqaili UL, et al.. Primary headache disorders in the adult general population of Pakistan - a cross sectional nationwide prevalence survey. J Headache Pain. 2017, 18:28. 10.1186\/s10194-017-0734-1","journal-title":"J Headache Pain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The pathophysiology of migraine: implications for clinical management","volume":"17","author":"Charles A","year":"2018","unstructured":"Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018, 17:174-82. 10.1016\/S1474-4422(17)30435-0","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01277.x","article-title":"The neurogenic basis of migraine","volume":"48","author":"Cutrer FM","year":"2008","unstructured":"Cutrer FM, Charles A. The neurogenic basis of migraine. Headache. 2008, 48:1411-4. 10.1111\/j.1526-4610.2008.01277.x","journal-title":"Headache"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0558-1","article-title":"Current status of antiepileptic drugs as preventive migraine therapy","volume":"21","author":"Parikh SK","year":"2019","unstructured":"Parikh SK, Silberstein SD. Current status of antiepileptic drugs as preventive migraine therapy. Curr Treat Options Neurol. 2019, 21:16. 10.1007\/s11940-019-0558-1","journal-title":"Curr Treat Options Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130733","article-title":"A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache","volume":"10","author":"Jackson JL","year":"2015","unstructured":"Jackson JL, Cogbill E, Santana-Davila R, et al.. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One. 2015, 10:e0130733. 10.1371\/journal.pone.0130733","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14581\/jer.17002","article-title":"Headache and epilepsy","volume":"7","author":"Kim DW","year":"2017","unstructured":"Kim DW, Lee SK. Headache and epilepsy. J Epilepsy Res. 2017, 7:7-15. 10.14581\/jer.17002","journal-title":"J Epilepsy Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-013-0236-7","article-title":"Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment","volume":"15","author":"Rodriguez-Sainz A","year":"2013","unstructured":"Rodriguez-Sainz A, Pinedo-Brochado A, S\u00e1nchez-Menoyo JL, Ruiz-Ojeda J, Escalza-Cortina I, Garcia-Monco JC. Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment. Curr Treat Options Cardiovasc Med. 2013, 15:322-34. 10.1007\/s11936-013-0236-7","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000001067","article-title":"High-field MRS study of GABA+ in patients with migraine: response to levetiracetam treatment","volume":"29","author":"Li Q","year":"2018","unstructured":"Li Q, Chen C, Gong T. High-field MRS study of GABA+ in patients with migraine: response to levetiracetam treatment. Neuroreport. 2018, 29:1007-10. 10.1097\/WNR.0000000000001067","journal-title":"Neuroreport"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/187152411794961086","article-title":"Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam","volume":"11","author":"Pizza V","year":"2011","unstructured":"Pizza V, Busillo V, Agresta A, Bisogno A, Capasso A. Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam. Cent Nerv Syst Agents Med Chem. 2011, 11:31-4. 10.2174\/187152411794961086","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.0000236766.08409.03","article-title":"Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study","volume":"29","author":"Brighina F","year":"2006","unstructured":"Brighina F, Palermo A, Aloisio A, Francolini M, Giglia G, Fierro B. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Clin Neuropharmacol. 2006, 29:338-42. 10.1097\/01.WNF.0000236766.08409.03","journal-title":"Clin Neuropharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-003-0043-8","article-title":"An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine","volume":"4","author":"Gallai V","year":"2003","unstructured":"Gallai V, Alberti A, Rossi C, Coppola F, Gallai B, Mazzotta G, Sarchielli P. An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine. J Headache Pain. 2003, 4:92-6. 10.1007\/s10194-003-0043-8","journal-title":"J Headache Pain"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.144290","article-title":"Comparison of Levetiracetam and sodium valproate in migraine prophylaxis: a randomized placebo-controlled study","volume":"18","author":"Sadeghian H","year":"2015","unstructured":"Sadeghian H, Motiei-Langroudi R. Comparison of Levetiracetam and sodium valproate in migraine prophylaxis: a randomized placebo-controlled study. Ann Indian Acad Neurol. 2015, 18:45-8. 10.4103\/0972-2327.144290","journal-title":"Ann Indian Acad Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000005","article-title":"Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India","volume":"36","author":"Verma A","year":"2013","unstructured":"Verma A, Srivastava D, Kumar A, Singh V. Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India. Clin Neuropharmacol. 2013, 36:193-7. 10.1097\/WNF.0000000000000005","journal-title":"Clin Neuropharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.06.076","article-title":"Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients","volume":"442","author":"de Tommaso M","year":"2008","unstructured":"de Tommaso M, Guido M, Sardaro M, et al.. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci Lett. 2008, 442:81-5. 10.1016\/j.neulet.2008.06.076","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410384886","article-title":"Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT])","volume":"31","author":"Beran RG","year":"2011","unstructured":"Beran RG, Spira PJ. Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]). Cephalalgia. 2011, 31:530-6. 10.1177\/0333102410384886","journal-title":"Cephalalgia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65894-levetiracetam-for-the-prophylaxis-of-migraine-in-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:26Z","timestamp":1707507206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65894-levetiracetam-for-the-prophylaxis-of-migraine-in-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.16779","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,31]]}}}